Carolinas Wealth Consulting’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-115
| Closed | -$1.67K | – | 1105 |
|
|
2022
Q4 | $1.67K | Sell |
115
-5
| -4% | -$73 | ﹤0.01% | 830 |
|
|
2022
Q3 | $2K | Hold |
120
| – | – | ﹤0.01% | 769 |
|
|
2022
Q2 | $2K | Hold |
120
| – | – | ﹤0.01% | 771 |
|
|
2022
Q1 | $3K | Hold |
120
| – | – | ﹤0.01% | 766 |
|
|
2021
Q4 | $3K | Buy |
120
+1
| +0.8% | +$25 | ﹤0.01% | 780 |
|
|
2021
Q3 | $4K | Hold |
119
| – | – | ﹤0.01% | 708 |
|
|
2021
Q2 | $4K | Sell |
119
-35
| -23% | -$1.18K | ﹤0.01% | 734 |
|
|
2021
Q1 | $5K | Buy |
154
+43
| +39% | +$1.4K | ﹤0.01% | 718 |
|
|
2020
Q4 | $2K | Sell |
111
-20
| -15% | -$360 | ﹤0.01% | 749 |
|
|
2020
Q3 | $2K | Buy |
+131
| New | +$2K | ﹤0.01% | 722 |
|